A highly regarded Funds Management and Investment Banking executive, Richard has over 25 years’ experience in capital markets spanning Asia-Pacific, Europe and the US – where he has held senior roles in equities research and institutional research sales. Richard is currently an equity analyst with Corporate Connect Research. Richard started his career as an exploration geologist for Freeport McMoran before moving to finance where he has held roles with Schroder Investment Management (Sydney/London), Deutsche Bank (UK), Citigroup (Aust), Credit Suisse (Aust) and Antares Equities/MLC Asset Management.
Tamboran Resources (ASX: TBN) has just been given a huge vote of confidence with one of the United States’ most successful shale gas investors investing A$20 million in the company.
Read More
The Beetaloo Basin is shaping up to be Australia’s next big hydrocarbon province, prompting some in the industry to proclaim it as one of the hottest shale gas plays in the world.
Read More
DOWNLOAD RESEARCH REPORTFast growing BNPL provider trading at discount to peer group
Laybuy Group Holdings (LBY) is a fast growing provider of buy-now-pay-later (BNPL) services, with a market leading position in NZ, and a growing presence in Australia and the UK.
The company has a market leading position in NZ BNPL, and a growing presence in Australia and the UK. The large UK retail market of £403b and ~28% online penetration represents a significant opportunity for LBY, with only ~1.7% BNPL adoption (~6% of online) leaving significant runway for growth. |
DOWNLOAD RESEARCH REPORTIncreasing our TargetDespite the lower realised oil and gas price, which fell by 5.4% and 19.7% respectively in August, Calima managed to show improvement in its key business metrics. We expect higher production in November due to the contribution by the new Thorsby wells which will be drilled in August/September which will see Calima meet its 2021 production guidance of 4,500 boe/d. |
DOWNLOAD RESEARCH REPORTEmerging Financial Wealth Advisory GroupWT Financial Group Limited (WTL) is a growing diversified financial services company, founded in 2010 and listed on the Australian Stock Exchange (ASX) in 2015. Its advice and product offerings are delivered primarily through a group of independent financial advisers operating as authorised representatives of WTL under its Wealth Today Pty Ltd (Wealth Today) and Sentry Group Pty Ltd (Sentry Group) dealer group operations. It has around 275 advisers across more than 200 financial advice practices Australia-wide. It also operates a direct-to-consumer operation under its Spring Financial Group brand. |
DOWNLOAD RESEARCH REPORTImmutep Taking the Fight to CancerIn May 2021, Corporate Connect analyst Marc Sinatra published a comprehensive research report on ASX-listed biotech Immutep Ltd (ASX: IMM). So impressed was he with IMM that Corporate Connect felt it imperative that a follow-up report be released placing a valuation on the company, because the market was not seeing the vast potential of eftilagimod alpha (efti). This follow-up report has been released today. Using comparables, after adding cash back to their EV estimate and dividing by the total number of issued shares, Corporate Connect now places the fair value of an Immutep share at $A2.20. |
Scoping Study determines 4.5-year payback for transformational Lake Throssell project• Trigg Mining has announced completion of a Scoping Study on the economic potential of its flagship Lake Throssell Sulphate of Potash project. The results demonstrate a compelling business case for the development of a major new long-life, sustainable SOP project, with strong financial returns. • Lake Throssell will produce 245ktpa SOP once ramped up, over an initial life of mine of 21 years. The estimated operating cash costs of $341/t SOP are low by global standards, and would place Lake Throssell in the lowest-cost quartile of the global SOP industry cost curve, based on CRU analysis. • Based on the new information released in the Scoping Study, we have updated our forecasts for the Lake Throssell project. We derive a DCF equity value for TMG of $0.37 per share, with potential upside as its projects de-risk through further development stages. We note TMG’s projects still remain in relatively early stages with associated higher levels of risk and uncertainty. |
DOWNLOAD RESEARCH REPORT |
DOWNLOAD RESEARCH REPORTStrategic Vanadium-battery growth with Titanium & Iron earnings resiliencyTNG Ltd is an ASX-listed technology owner and developer of the world-class Mount Peake near-surface vanadifferous titanomagnetite deposit. To unlock value, TNG will concentrate ore from its central Northern Territory mine for processing through its patented TIVAN® process produce three premium quality revenue streams: hi-purity vanadium pentoxide (V2O5) for steel alloys and Vanadium Redox Flow batteries, a quality titanium pigment for paints and a premium steel input with >64%Fe iron ore fines. |
DOWNLOAD RESEARCH REPORTPaediatric Investigation Plan Almost Certain To Get the Tick and Other Notable EventsAntisense Therapeutics reported on Friday 30 September (2021), that it had received a draft opinion recommending agreement with the company’s Paediatric Investigation Plan (PIP) for the development of ATL1102 for Duchenne muscular dystrophy (DMD) from the Paediatric Committee (PDCO) for the European Medicines Agency (EMA). This is not a final decision, but we understand it is very unusual for the EMA not to adopt a recommended PIP. |
DOWNLOAD RESEARCH REPORTAccelerating free cashflow secures funding; & boosts re-rating potentialThermal coal prices in export markets have continued to strengthen into the SepQ21 and producer currencies have weakened allowing record coal pricing in Australian dollar terms. Around half of TER’s coal is export thermal coal and earnings are highly leveraged with a US$10/t rise for the remaining FY22, equating to ~13.7% rise on our base expectation of EPS in FY22 of $0.15/share. |
DOWNLOAD RESEARCH REPORTLilac Solution Inc backs its own tech – taking equity in KachiLake Resources has announced that its clean technology partner Lilac Solutions Ltd, will join the Argentinian Kachi project, earning up to 25% at the asset level, subject to performance hurdles. Lilac brings a new-patented technology to the lithium brine industry and its direct investment further reduces perceived funding and technology risk and increases the likelihood of project delivery. |
DOWNLOAD RESEARCH REPORTPhillips 66 to acquire 16% in NVX – 12-month target price rises 7% through project de-riskingPhillips 66 (PSX) has entered into an agreement with NVX to acquire 77.9m new shares for US$150m (A$203m). PSX is the worlds largest producer of speciality petroleum coke a precursor for battery grade synthetic graphite anode materials found with an Enterprise Value of US$47.5Bn and assets of US$57Bn. |
DOWNLOAD RESEARCH REPORTMarket leading lifelong learning platform technology company in Australia and SE AsiaPayGroup (PYG) delivers multi-country BPO services and cloud SaaS HCM solutions, assisting companies to manage employees in multiple, complex jurisdictions. The company has many growth opportunities, including new clients, new jurisdictions, new products, partner expansion, and new revenue sources. PYG’s scalable business model allows operating leverage and with savings from in-housing third party technology, support margin expansion. |
DOWNLOAD RESEARCH REPORTMarket leading lifelong learning platform technology company in Australia and SE AsiaOpenLearning (OLL) is a higher education technology company that operates a scalable online learning platform through a software-as-a-service (SaaS) business model and provides a global marketplace of high quality courses for learners of all levels. Its primary customers are education providers based in Australia and South-East Asia (primarily Malaysia). OLL started operations in Australia in 2012 and expanded to Malaysia in 2015, Singapore in 2018, and recently also Indonesia. |
DOWNLOAD RESEARCH REPORTDo Two A+ Deals Foreshadow THE DEAL?Licensing deals are the life blood of small pharmaceutical companies, representing their exit from the development of a molecule, often in a staged manner, and a coalescing of the value they have added to a compound. Kazia Therapeutics has done two licensing deals in the space of a month, something unique for an Australian company. In this report, we look at those deals, assess their quality and look at other takeaways they provide. |
